DE3124698C2 - - Google Patents
Info
- Publication number
- DE3124698C2 DE3124698C2 DE3124698A DE3124698A DE3124698C2 DE 3124698 C2 DE3124698 C2 DE 3124698C2 DE 3124698 A DE3124698 A DE 3124698A DE 3124698 A DE3124698 A DE 3124698A DE 3124698 C2 DE3124698 C2 DE 3124698C2
- Authority
- DE
- Germany
- Prior art keywords
- weight
- erythromycin
- benzoyl peroxide
- gel
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 claims description 56
- 239000000203 mixture Substances 0.000 claims description 51
- 239000004342 Benzoyl peroxide Substances 0.000 claims description 29
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 claims description 29
- 235000019400 benzoyl peroxide Nutrition 0.000 claims description 29
- 229960003276 erythromycin Drugs 0.000 claims description 28
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 claims description 12
- CDOUZKKFHVEKRI-UHFFFAOYSA-N 3-bromo-n-[(prop-2-enoylamino)methyl]propanamide Chemical compound BrCCC(=O)NCNC(=O)C=C CDOUZKKFHVEKRI-UHFFFAOYSA-N 0.000 claims description 11
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 11
- 206010000496 acne Diseases 0.000 claims description 11
- -1 erythromycin compound Chemical class 0.000 claims description 10
- 238000011282 treatment Methods 0.000 claims description 9
- 239000002245 particle Substances 0.000 claims description 5
- 229960003328 benzoyl peroxide Drugs 0.000 claims description 4
- 230000001476 alcoholic effect Effects 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 30
- 239000000499 gel Substances 0.000 description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- 235000019441 ethanol Nutrition 0.000 description 13
- 239000008213 purified water Substances 0.000 description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- 229920002125 Sokalan® Polymers 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 150000002978 peroxides Chemical class 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 238000009472 formulation Methods 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- 125000000217 alkyl group Chemical class 0.000 description 4
- 239000003349 gelling agent Substances 0.000 description 4
- 229920000151 polyglycol Polymers 0.000 description 4
- 239000010695 polyglycol Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical group CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 3
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 229960001047 methyl salicylate Drugs 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 229920000570 polyether Polymers 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 208000020154 Acnes Diseases 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- KQNZLOUWXSAZGD-UHFFFAOYSA-N benzylperoxymethylbenzene Chemical compound C=1C=CC=CC=1COOCC1=CC=CC=C1 KQNZLOUWXSAZGD-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- 235000021588 free fatty acids Nutrition 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229960004793 sucrose Drugs 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- YAVZHCFFUATPRK-YZPBMOCRSA-N Erythromycin stearate Chemical compound CCCCCCCCCCCCCCCCCC(O)=O.O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 YAVZHCFFUATPRK-YZPBMOCRSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 101710158368 Extracellular lipase Proteins 0.000 description 1
- 206010058015 Infected cyst Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 206010039580 Scar Diseases 0.000 description 1
- 244000127759 Spondias lutea Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 101710128940 Triacylglycerol lipase Proteins 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- FATUQANACHZLRT-KMRXSBRUSA-L calcium glucoheptonate Chemical compound [Ca+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)C([O-])=O FATUQANACHZLRT-KMRXSBRUSA-L 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000001687 destabilization Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
- 229940043276 diisopropanolamine Drugs 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- YHAIUSTWZPMYGG-UHFFFAOYSA-L disodium;2,2-dioctyl-3-sulfobutanedioate Chemical compound [Na+].[Na+].CCCCCCCCC(C([O-])=O)(C(C([O-])=O)S(O)(=O)=O)CCCCCCCC YHAIUSTWZPMYGG-UHFFFAOYSA-L 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229960004142 erythromycin stearate Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- PGBHMTALBVVCIT-VCIWKGPPSA-N framycetin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO PGBHMTALBVVCIT-VCIWKGPPSA-N 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229940053050 neomycin sulfate Drugs 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000010525 oxidative degradation reaction Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- VWSUVZVPDQDVRT-UHFFFAOYSA-N phenylperoxybenzene Chemical compound C=1C=CC=CC=1OOC1=CC=CC=C1 VWSUVZVPDQDVRT-UHFFFAOYSA-N 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/38—Percompounds, e.g. peracids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/88—Two- or multipart kits
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21412480A | 1980-12-08 | 1980-12-08 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE3124698A1 DE3124698A1 (de) | 1982-07-08 |
| DE3124698C2 true DE3124698C2 (enExample) | 1992-06-25 |
Family
ID=22797872
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19813124698 Granted DE3124698A1 (de) | 1980-12-08 | 1981-06-24 | Oertlich anwendbares praeparat fuer die behandlung von akne |
Country Status (18)
| Country | Link |
|---|---|
| JP (1) | JPS5799525A (enExample) |
| AR (1) | AR229405A1 (enExample) |
| AT (1) | AT381452B (enExample) |
| AU (1) | AU557147B2 (enExample) |
| BE (1) | BE889327A (enExample) |
| CA (1) | CA1179599A (enExample) |
| CH (2) | CH647147A5 (enExample) |
| DE (1) | DE3124698A1 (enExample) |
| DK (1) | DK273981A (enExample) |
| ES (1) | ES503797A0 (enExample) |
| FR (1) | FR2495471A1 (enExample) |
| GB (2) | GB2090135A (enExample) |
| IT (1) | IT1210608B (enExample) |
| NL (1) | NL8102997A (enExample) |
| NZ (1) | NZ197491A (enExample) |
| PH (1) | PH19245A (enExample) |
| SE (1) | SE8103925L (enExample) |
| ZA (1) | ZA814215B (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA837627B (en) * | 1982-10-15 | 1984-06-27 | Procter & Gamble | Storage stable topical pharmaceutical composition containing low dielectric solvents |
| DE3375376D1 (en) * | 1982-10-15 | 1988-02-25 | Procter & Gamble | Storage stable topical pharmaceutical composition including nitrogen-containing stabilizers |
| FR2558372B1 (fr) * | 1984-01-25 | 1987-08-07 | Oreal | Composition medicamenteuse pour le traitement de l'acne |
| HU193777B (en) * | 1985-06-18 | 1987-11-30 | Biogal Gyogyszergyar | Preparation against acne and process for preparing the same |
| FR2604357B1 (fr) * | 1986-09-30 | 1988-12-02 | Oreal | Composition pharmaceutique et cosmetique anti-acneique |
| JPS6452724A (en) * | 1987-05-19 | 1989-02-28 | Yakurigaku Chuo Kenkyusho Kk | Novel synthetic aluminum silicate preparation |
| US5260292A (en) * | 1991-03-05 | 1993-11-09 | Marvin S. Towsend | Topical treatment of acne with aminopenicillins |
| TW203552B (en) * | 1992-02-18 | 1993-04-11 | J Baroody Lloyd | Compositions of clindamycin and benzoyl peroxide for acne treatment |
| IL105217A0 (en) * | 1992-04-09 | 1993-07-08 | Allergan Inc | Method and composition for treating acne |
| US5470884A (en) * | 1994-05-19 | 1995-11-28 | Procter & Gamble | Anti-acne compositions |
| AU9259598A (en) * | 1997-07-08 | 1999-02-08 | Gist-Brocades B.V. | Topical application of a combination of benzoyl peroxide and a second active ingredient |
| DE19917548A1 (de) * | 1999-04-19 | 2000-10-26 | August Wolff Gmbh & Co Arzneim | Pharmazeutische Zusammensetzung auf der Basis von Erythromycin-Fettsäuresalzen mit 12 bis 22 Kohlenstoffatomen im Fettsäurerest und Verwendung dieser Erythromycin-Fettsäuresalze zur topischen Behandlung von Hauterkrankungen |
| AR028666A1 (es) * | 2000-06-02 | 2003-05-21 | Dermik Internat Holding Inc De | Composicion para el tratamiento del acne |
| US7060732B2 (en) * | 2000-12-12 | 2006-06-13 | Imaginative Research Associates, Inc. | Antibiotic/benzoyl peroxide dispenser |
| US6495158B1 (en) | 2001-01-19 | 2002-12-17 | Lec Tec Corporation | Acne patch |
| US7820186B2 (en) | 2001-12-21 | 2010-10-26 | Galderma Research & Development | Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt |
| GB0301577D0 (en) * | 2003-01-23 | 2003-02-26 | Edko Pazarlama Tanitim Ltd Sti | Topical pharmaceutical and/or cosmetic dispense systems |
| JP5155849B2 (ja) * | 2005-03-10 | 2013-03-06 | ジェイアール ケム エルエルシー | 安定性有機過酸化物組成物 |
| WO2007092312A2 (en) | 2006-02-03 | 2007-08-16 | Stiefel Laboratories, Inc. | Topical skin treating compositions |
| FR2903604B1 (fr) * | 2006-07-13 | 2008-09-05 | Galderma Res & Dev S N C Snc | Composition comprenant un retinoide et du peroxyde de benzoyle |
| CA2656451C (en) * | 2006-07-13 | 2015-01-27 | Galderma Research & Development | Composition comprising a retinoid and benzoyl peroxide |
| FR2910321B1 (fr) | 2006-12-21 | 2009-07-10 | Galderma Res & Dev S N C Snc | Gel creme comprenant au moins un retinoide et du peroxyde de benzole |
| FR2910320B1 (fr) | 2006-12-21 | 2009-02-13 | Galderma Res & Dev S N C Snc | Emulsion comprenant au moins un retinoide et du peroxyde de benzole |
| ES2763829T3 (es) | 2007-02-01 | 2020-06-01 | Sol Gel Tech Ltd | Método para preparar partículas que comprenden un revestimiento de óxido de metal |
| ES2773931T3 (es) * | 2008-06-05 | 2020-07-15 | Bausch Health Ireland Ltd | Formulaciones farmacéuticas tópicas que contienen una baja concentración de peróxido de benzoílo en suspensión en agua y un solvente orgánico miscible en agua |
| FR2953832B1 (fr) | 2009-12-10 | 2012-01-13 | Galderma Res & Dev | Derives de nouveaux peroxydes, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique pour le traitement ou la prevention de l'acne |
| FR2953833B1 (fr) | 2009-12-10 | 2012-01-13 | Galderma Res & Dev | Derives de nouveaux peroxydes, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique pour le traitement ou la prevention de l'acne |
| HUE073201T2 (hu) | 2017-07-12 | 2026-01-28 | Sol Gel Tech Ltd | Kapszulázott tretinoint tartalmazó készítmények |
| JP6525074B2 (ja) | 2017-07-31 | 2019-06-05 | 大日本印刷株式会社 | 熱転写シート、印画シートと熱転写シートとの組合せ、及び熱転写印画装置 |
| WO2023243935A1 (ko) * | 2022-06-14 | 2023-12-21 | 이승창 | 여드름 예방 또는 치료용 약학 조성물 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1090253A (en) * | 1976-11-01 | 1980-11-25 | Edward D. Thompson | Anti-acne composition |
| FR2378523A1 (fr) * | 1977-01-26 | 1978-08-25 | Grupper Charles | Medicament pour le traitement de l'acne |
-
1981
- 1981-06-18 IT IT8167845A patent/IT1210608B/it active
- 1981-06-19 CA CA000380219A patent/CA1179599A/en not_active Expired
- 1981-06-22 BE BE0/205167A patent/BE889327A/fr not_active IP Right Cessation
- 1981-06-22 AU AU72029/81A patent/AU557147B2/en not_active Expired
- 1981-06-22 FR FR8112233A patent/FR2495471A1/fr not_active Withdrawn
- 1981-06-22 ZA ZA814215A patent/ZA814215B/xx unknown
- 1981-06-22 DK DK273981A patent/DK273981A/da not_active Application Discontinuation
- 1981-06-22 NZ NZ197491A patent/NZ197491A/xx unknown
- 1981-06-22 NL NL8102997A patent/NL8102997A/nl not_active Application Discontinuation
- 1981-06-22 ES ES503797A patent/ES503797A0/es active Granted
- 1981-06-23 SE SE8103925A patent/SE8103925L/xx unknown
- 1981-06-23 GB GB8119333A patent/GB2090135A/en not_active Withdrawn
- 1981-06-24 DE DE19813124698 patent/DE3124698A1/de active Granted
- 1981-06-24 PH PH25809A patent/PH19245A/en unknown
- 1981-06-25 CH CH4215/81A patent/CH647147A5/de not_active IP Right Cessation
- 1981-06-25 CH CH186/85A patent/CH656307A5/de not_active IP Right Cessation
- 1981-06-26 AT AT0285581A patent/AT381452B/de not_active IP Right Cessation
- 1981-07-27 AR AR286227A patent/AR229405A1/es active
- 1981-10-27 JP JP56170865A patent/JPS5799525A/ja active Pending
- 1981-12-07 GB GB8136777A patent/GB2088717B/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NL8102997A (nl) | 1982-07-01 |
| NZ197491A (en) | 1985-02-28 |
| ZA814215B (en) | 1983-02-23 |
| IT1210608B (it) | 1989-09-14 |
| CH647147A5 (de) | 1985-01-15 |
| BE889327A (fr) | 1981-10-16 |
| CH656307A5 (de) | 1986-06-30 |
| AU557147B2 (en) | 1986-12-11 |
| ES8303087A1 (es) | 1983-03-01 |
| GB2088717A (en) | 1982-06-16 |
| CA1179599A (en) | 1984-12-18 |
| GB2090135A (en) | 1982-07-07 |
| DK273981A (da) | 1982-09-09 |
| SE8103925L (sv) | 1982-06-09 |
| PH19245A (en) | 1986-02-14 |
| AR229405A1 (es) | 1983-08-15 |
| IT8167845A0 (it) | 1981-06-18 |
| ATA285581A (de) | 1986-03-15 |
| JPS5799525A (en) | 1982-06-21 |
| FR2495471A1 (fr) | 1982-06-11 |
| AU7202981A (en) | 1982-06-17 |
| GB2088717B (en) | 1984-12-12 |
| AT381452B (de) | 1986-10-27 |
| DE3124698A1 (de) | 1982-07-08 |
| ES503797A0 (es) | 1983-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH656307A5 (de) | Praeparat fuer die oertliche behandlung der akne. | |
| DE69427639T3 (de) | Verwendung von nicht-ionischen oberflächenaktiven substanzen in retinoid enthaltenden stabilen topischen zusammensetzungen | |
| DE69427589T2 (de) | Neue zusammensetzung | |
| DE2913296C2 (enExample) | ||
| DE69832545T2 (de) | Aufgelöste Ethylzellulose enthaltende topische Zusammensetzung frei von einwertigen Alkohol | |
| EP0556660B1 (de) | Verwendungen von alpha-Hydroxyfettsäuren | |
| DE60016670T2 (de) | Kosmetische Mittel, die mindestens ein Hydroxystilben und Ascorbinsäure enthalten | |
| DE69716251T2 (de) | Verwendung von oktoxyglyzerin in einer kosmetischen und/oder dermatologischen zusammensetzung als wirkstoff zur behandlung von seborrhoe und/oder akne | |
| DE3732840A1 (de) | Pharmazeutische und kosmetische anti-akne-zusammensetzung | |
| DE19531893A1 (de) | Juckreizmildernde, kosmetische und/oder pharmazeutische Zusammensetzungen | |
| EP0439042A1 (de) | Verwendung von pharmazeutischen und kosmetischen Präparaten mit Mischmicellen | |
| DE1934334B2 (de) | Wasserfreies Präparat auf Basis gesättigter Fettalkohole und Glykollösungsmittel | |
| DE69819443T2 (de) | Antimikrobielle mittel zur topische verwendung | |
| DD298352A5 (de) | Tretinoin enthaltende zubereitung und verfahren zu ihrer herstellung | |
| DE69916695T2 (de) | Verwendung mindestens eines Hydroxystilben als Mittel zur Verringerung der Adhäsion von Mikroorganismen | |
| DE2601489C2 (enExample) | ||
| DE19747600C2 (de) | Nichtionische Vitamin E-Derivate oder polyethoxylierte Vitamin E-Derivate und Verfahren zu ihrer Herstellung sowie ihre Verwendung | |
| DE3049722C2 (de) | Zur Behandlung von Akne und Seborrhoe geeignete, wäßrige Benzoylperoxidzusammensetzung | |
| DE4431251A1 (de) | Hautcreme | |
| DE69019517T2 (de) | Neolignanderivatkomplexen mit Phospolipiden, deren Verwendung und sie enthaltende pharmazeutische und kosmetische Zusammensetzungen. | |
| EP1206245A2 (de) | Phospholipidgel | |
| DE2924878A1 (de) | Insektizide und akarizide mittel in form von oel-in-wasser-emulsionen | |
| DE3540175C2 (de) | Dithranolhaltige pharmazeutische Zubereitung | |
| DE60027127T2 (de) | Verwendung von Polyaminosäurederivaten zur Behandlung von Seborrhoe und verwandten Hautstörungen | |
| EP2056781B1 (de) | Wasserfreie, harnstoffhaltige, dermatologische oder kosmetische zubereitung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| D2 | Grant after examination | ||
| 8328 | Change in the person/name/address of the agent |
Free format text: STOLBERG-WERNIGERODE, GRAF ZU, U., DIPL.-CHEM. DR.RER.NAT. SUCHANTKE, J., DIPL.-ING. HUBER, A., DIPL.-ING. KAMEKE, VON, A., DIPL.-CHEM. DR.RER.NAT., 2000 HAMBURG SCHULMEYER, K., DIPL.-CHEM. DR.RER.NAT., PAT.-ANWAELTE, 2087 HASLOH |
|
| 8364 | No opposition during term of opposition |